法国东部婴儿肠套叠危险因素的病例对照研究:轮状病毒疫苗引入后
该病例对照研究纳入2008年4月至2012年3月法国东部因疑似肠套叠急诊入院的<1岁婴儿,将Brighton分类1级病例与4名医院对照匹配,分析轮状病毒疫苗接种等危险因素。共匹配115例病例与457名对照,4年平均疫苗接种覆盖率8.6%。轮状病毒疫苗与肠套叠发生无显著关联,而单纯或混合母乳喂养的婴儿配方奶及入院前2周内胃肠炎史与肠套叠风险升高相关。
要点
- 轮状病毒疫苗与肠套叠无显著关联,但疫苗覆盖率低可能影响检测效能
- 单纯或混合配方奶喂养与肠套叠风险升高相关(OR 2.74)
- 入院前2周内胃肠炎史与肠套叠风险升高相关(OR 2.24)
核心结论
- 单纯或混合母乳喂养的婴儿配方奶是肠套叠的危险因素。
- 轮状病毒疫苗接种后肠套叠风险有小幅非显著增加,低疫苗覆盖率可能妨碍检测显著风险增加。
研究设计与样本
- 病例对照研究,系统纳入2008年4月1日至2012年3月31日法国东部急诊入院的<1岁疑似肠套叠婴儿。
- Brighton分类1级病例与4名医院对照匹配,共115例病例与457名对照。
- 检查两个暴露窗口:首剂轮状病毒疫苗后7天和14天内。
主要发现
- 4年研究期间平均疫苗接种覆盖率为8.6%。
- 轮状病毒疫苗与肠套叠在7天内无显著关联(OR未计算;p=0.99)。
- 轮状病毒疫苗与肠套叠在14天内无显著关联(OR 1.33,95%CI 0.14-12.82)。
- 单纯或混合母乳喂养的婴儿配方奶与肠套叠风险升高相关(OR 2.74,95%CI 1.10-6.79)。
- 入院前2周内胃肠炎史与肠套叠风险升高相关(OR 2.24,95%CI 1.07-4.67)。
临床怎么用
- 评估婴儿肠套叠风险时应考虑喂养方式(配方奶喂养)和近期胃肠炎史。
- 在低轮状病毒疫苗覆盖率背景下,疫苗接种后肠套叠风险监测仍需持续。
局限性
- 低疫苗覆盖率可能妨碍检测轮状病毒疫苗接种后肠套叠风险的显著增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the present study was to investigate the risk factors for intussusception (IS) among infants, including vaccination against rotavirus. METHODS: Case-control study with systematic inclusion of all infants aged <1 year with suspected IS admitted to emergency departments in the eastern region of France between 1 April 2008 and 31 March 2012. All cases classed level 1 according to the Brighton classification were matched to 4 hospital controls. Two exposure windows were examined; exposure to the first dose of rotavirus vaccine in the 7 and in the 14 days prior to the occurrence of IS. RESULTS: A total of 115 cases were matched with 457 controls. The average vaccination coverage rate over the 4 years of study was 8.6%. Rotavirus vaccine was not found to be significantly associated with the occurrence of IS in the 7 days (odds ratio (OR) not calculated; p = 0.99) and in the 14 days after administration of one dose vaccine (OR 1.33, 95% confidence interval (CI) 0.14-12.82). Infant formula alone or combined with breastfeeding was associated with an excess risk of IS (OR 2.74, 95% CI 1.10-6.79). A history of gastroenteritis within 2 weeks prior to hospitalisation was also associated with an increased risk (OR 2.24, 95% CI 1.07-4.67). CONCLUSION: Our study indicates that infant formula alone or combined with breastfeeding is a risk factor for IS. A small, non-significant increase in the risk of IS was observed after rotavirus vaccination, although the low vaccine coverage rate likely precluded detection of a significant increase in risk.
引用
- Fotso Kamdem A, Vidal C, Pazart L, et al. A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine. Vaccine. 2019. PMID: 30851968. doi:10.1016/j.vaccine.2019.02.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。